tiprankstipranks
Sensei Biotherapeutics (SNSE)
NASDAQ:SNSE
US Market
SNSE
Sensei Biotherapeutics
RESEARCH TOOLSreports
Want to see SNSE full AI Analyst Report?

Sensei Biotherapeutics (SNSE) Financial Statements

234 Followers

Sensei Biotherapeutics Financial Overview

Sensei Biotherapeutics's market cap is currently $42.61M. The company's EPS TTM is $-3.79; its P/E ratio is -0.71; Sensei Biotherapeutics is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -551.00K$ -571.00K$ -1.81M$ -685.00K
Operating Income$ -22.29M$ -31.66M$ -37.06M$ -49.12M$ -37.48M
EBITDA$ -20.91M$ -29.52M$ -33.39M$ -46.56M$ -35.44M
Net Income$ -21.09M$ -30.16M$ -34.10M$ -48.59M$ -36.79M
Balance Sheet
Cash & Short-Term Investments$ 21.18M$ 41.34M$ 65.76M$ 107.12M$ 147.62M
Total Assets$ 22.90M$ 45.36M$ 74.37M$ 118.38M$ 153.22M
Total Debt$ 1.51M$ 3.85M$ 6.21M$ 8.03M$ 2.35M
Net Debt$ -7.16M$ -6.15M$ -6.80M$ -9.76M$ -4.80M
Total Liabilities$ 4.31M$ 6.97M$ 9.48M$ 14.97M$ 6.71M
Stockholders' Equity$ 18.59M$ 38.39M$ 64.89M$ 103.41M$ 146.51M
Cash Flow
Free Cash Flow$ -20.47M$ -24.82M$ -32.20M$ -39.35M$ -32.28M
Operating Cash Flow$ -20.45M$ -24.67M$ -32.02M$ -39.03M$ -30.26M
Investing Cash Flow$ 19.77M$ 22.44M$ 38.41M$ 49.95M$ -143.12M
Financing Cash Flow$ -645.00K$ -787.00K$ -11.17M$ -287.00K$ 163.94M
Currency in USD

Sensei Biotherapeutics Earnings and Revenue History

Income Statement >

Sensei Biotherapeutics Debt to Assets

Balance Sheet >

Sensei Biotherapeutics Cash Flow

Cash Flow >

Sensei Biotherapeutics Forecast EPS vs Actual EPS

Earnings >